SUDAIR PHARMA COMPANY

Sudair Pharma Company (SPC) is a Saudi-based pharmaceutical company. SPC was established in 2014 to set-up a pharmaceutical complex focusing on local production of high-end generic drugs for cancer treatment and to produce other pharma solutions locally in the GCC to combat chronic diseases. GIC owns an equity stake of 35% in SPC.